Therapeutic whole blood exchange in the management of methaemoglobinemia: Case series and systematic review of literature
- PMID: 32017306
- DOI: 10.1111/tme.12666
Therapeutic whole blood exchange in the management of methaemoglobinemia: Case series and systematic review of literature
Abstract
Background: Therapeutic whole blood exchange (TWBE) has been used as an alternative when methylene blue (MB) fails in severe methaemoglobinemia. However, there are limited data on the efficacy and safety of TWBE.
Objectives: Our aim was to report our institutional experience with TWBE. We also perform a systematic review of published literature.
Methods: We retrospectively reviewed our respiratory intensive care unit database to identify cases of methaemoglobinemia managed with TWBE. A systematic review of the PubMed database was performed to identify similar cases (≥12 years). We report the indications, utility, and safety of therapeutic exchange in methaemoglobinemia. The procedural details were also noted.
Results: We identified five subjects who received TWBE for methaemoglobinemia (median methaemoglobin level 39%; range 19.6-42.4%). TWBE was successful in all five cases and no adverse events were encountered. Our review identified 27 additional subjects. The median methaemoglobin level was 37.5% (range 3.7-81%). The most common indication (n = 24, 75%) for therapeutic exchange was a lack of response to MB. A majority of the subjects (n = 26/32, 81.2%) survived. No procedure-related complications were reported.
Conclusion: TWBE is a safe and effective salvage modality for adults with methaemoglobinemia, when MB is either contraindicated or ineffective. Future studies should standardise therapeutic exchange in the management of methaemoglobinemia.
Keywords: G-6-PD deficiency; apheresis; haemolysis; methaemoglobinemia; plasmapheresis; red blood cell exchange; saturation gap.
© 2020 British Blood Transfusion Society.
Similar articles
-
Nitrobenzene induced methemoglobinemia treated with manual exchange transfusion in a resource-limited setting: a case report.Ann Med Surg (Lond). 2025 Mar 27;87(4):2449-2452. doi: 10.1097/MS9.0000000000003147. eCollection 2025 Apr. Ann Med Surg (Lond). 2025. PMID: 40212171 Free PMC article.
-
[Acquired methemoglobinemia: a case report].Pediatr Med Chir. 1998 Nov-Dec;20(6):411-3. Pediatr Med Chir. 1998. PMID: 10335542 Italian.
-
A bedside test for methaemoglobinemia improved antidote use in propanil poisoning.Clin Toxicol (Phila). 2016 Aug;54(7):576-80. doi: 10.1080/15563650.2016.1177651. Epub 2016 May 19. Clin Toxicol (Phila). 2016. PMID: 27196813
-
Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue.Toxicol Rev. 2003;22(1):13-27. doi: 10.2165/00139709-200322010-00003. Toxicol Rev. 2003. PMID: 14579544 Review.
-
Life-threatening Pyridium Plus intoxication: a case report.Pediatr Emerg Care. 1994 Aug;10(4):225-8. doi: 10.1097/00006565-199408000-00011. Pediatr Emerg Care. 1994. PMID: 7937302 Review.
Cited by
-
Phenazopyridine-Induced Methemoglobinemia in a Jehovah's Witness Treated with High-Dose Ascorbic Acid Due to Methylene Blue Contradictions: A Case Report and Review of the Literature.Hematol Rep. 2023 May 24;15(2):325-330. doi: 10.3390/hematolrep15020034. Hematol Rep. 2023. PMID: 37367083 Free PMC article.
-
SARS-CoV-2 infection, pulse oximetry, and interpretive caveats.Trop Doct. 2022 Oct;52(4):593-595. doi: 10.1177/00494755221094983. Epub 2022 Jul 1. Trop Doct. 2022. PMID: 35775134 Free PMC article.
-
A Case of Severe Hypoxia Caused by Phenazopyridine-Induced Methemoglobinemia: A near Fatal Event from Over-the-Counter Medication Use.Clin Pract. 2022 Oct 27;12(6):845-851. doi: 10.3390/clinpract12060089. Clin Pract. 2022. PMID: 36412668 Free PMC article.
-
Methaemalbumin: a diagnostic surrogate for methaemoglobinaemia and treatment with red cell exchange in a patient with thalassaemia.BMJ Case Rep. 2023 Mar 7;16(3):e252885. doi: 10.1136/bcr-2022-252885. BMJ Case Rep. 2023. PMID: 36882261 Free PMC article.
-
Recommendations for diagnosis and treatment of methemoglobinemia.Am J Hematol. 2021 Dec 1;96(12):1666-1678. doi: 10.1002/ajh.26340. Epub 2021 Sep 23. Am J Hematol. 2021. PMID: 34467556 Free PMC article. Review.
References
REFERENCES
-
- Percy MJ, McFerran NV, Lappin TR. Disorders of oxidised haemoglobin. Blood Rev. 2005;19(2):61-68.
-
- Bradberry SM. Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue. Toxicol Rev. 2003;22(1):13-27.
-
- Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J. 2011;104(11):757-761.
-
- Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005;51(2):434.
-
- Patnaik S, Natarajan MM, James EJ, Ebenezer K. Methylene blue unresponsive methemoglobinemia. Indian J Crit Care Med. 2014;18(4):253-255.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous